Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The IBD international genetics consortium provides further evidence for linkage to IBD4 and shows gene-environment interaction.
Pierik M, Yang H, Barmada MM, Cavanaugh JA, Annese V, Brant SR, Cho JH, Duerr RH, Hugot JP, McGovern DP, Paavola-Sakki P, Radford-Smith GL, Pavli P, Silverberg MS, Schreiber S, Taylor KD, Vlietinck R; IBD International Genetics Consortium. Pierik M, et al. Among authors: pavli p. Inflamm Bowel Dis. 2005 Jan;11(1):1-7. doi: 10.1097/00054725-200501000-00001. Inflamm Bowel Dis. 2005. PMID: 15674107
Ulcerative colitis: a genetic disease?
Cavanaugh JA, Pavli P. Cavanaugh JA, et al. Among authors: pavli p. Baillieres Clin Gastroenterol. 1997 Mar;11(1):1-15. doi: 10.1016/s0950-3528(97)90050-6. Baillieres Clin Gastroenterol. 1997. PMID: 9192057 Review.
Inflammatory bowel disease: germs or genes?
Pavli P, Cavanaugh J, Grimm M. Pavli P, et al. Lancet. 1996 May 4;347(9010):1198. doi: 10.1016/s0140-6736(96)90727-8. Lancet. 1996. PMID: 8622443 No abstract available.
Prevalence of Yersinia Species in the Ileum of Crohn's Disease Patients and Controls.
Le Baut G, O'Brien C, Pavli P, Roy M, Seksik P, Tréton X, Nancey S, Barnich N, Bezault M, Auzolle C, Cazals-Hatem D, Viala J, Allez M; REMIND GROUP; Hugot JP, Dumay A. Le Baut G, et al. Among authors: pavli p. Front Cell Infect Microbiol. 2018 Sep 21;8:336. doi: 10.3389/fcimb.2018.00336. eCollection 2018. Front Cell Infect Microbiol. 2018. PMID: 30298122 Free PMC article.
Entyvio lengthen dose-interval study: lengthening vedolizumab dose interval and the risk of clinical relapse in inflammatory bowel disease.
Chan W, Lynch N, Bampton P, Chang J, Chung A, Florin T, Hetzel DJ, Jakobovits S, Moore G, Pavli P, Radford-Smith G, Thin L, Baraty B, Haifer C, Yau Y, Leong RWL. Chan W, et al. Among authors: pavli p. Eur J Gastroenterol Hepatol. 2018 Jul;30(7):735-740. doi: 10.1097/MEG.0000000000001150. Eur J Gastroenterol Hepatol. 2018. PMID: 29727386
Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease.
Selby W, Pavli P, Crotty B, Florin T, Radford-Smith G, Gibson P, Mitchell B, Connell W, Read R, Merrett M, Ee H, Hetzel D; Antibiotics in Crohn's Disease Study Group. Selby W, et al. Among authors: pavli p. Gastroenterology. 2007 Jun;132(7):2313-9. doi: 10.1053/j.gastro.2007.03.031. Epub 2007 Mar 21. Gastroenterology. 2007. PMID: 17570206 Clinical Trial.
93 results